Immunic Inc.

NASDAQ: IMUX · Real-Time Price · USD
0.90
-0.02 (-1.80%)
At close: Aug 15, 2025, 3:59 PM
0.91
1.27%
After-hours: Aug 15, 2025, 07:58 PM EDT

Immunic Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
114K 114K 114K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
185K 173K 156K 122K 114K 105K 111K 107K 90K 88K 77K 98K 97K 92K 85K 45K 29K 14K
Gross Profit
-71K -59K -42K -122K -114K -105K -111K -107K -90K -88K -77K -98K -97K -92K -85K -45K -29K -14K
Operating Income
-105.27M -101M -98.05M -95.8M -93.65M -95.85M -99.22M -133.17M -129.72M -125.3M -119.49M -83.88M -82.15M -80.71M -91.67M -84.13M -79.29M -72.34M
Interest Income
1.63M 2.39M 3.39M 3.5M 3.49M 3.46M 3.08M 3.23M 2.7M 1.83M 1.04M 358K 138K 45K 66K 61K 71K 62K
Pretax Income
-101.84M -96.4M -100.51M -96.9M -95.31M -97.92M -93.61M -128.51M -126.97M -124.87M -120.41M -85.12M -83.19M -79.22M -92.94M -82.92M -76.54M -70.06M
Net Income
-101.84M -96.4M -100.51M -96.9M -95.31M -97.92M -91.6M -158.62M -158.18M -156.09M -153M -85.6M -82.56M -78.59M -92.94M -82.92M -76.54M -70.06M
Selling & General & Admin
19.38M 18.12M 17.95M 18.03M 17.45M 16.84M 16.01M 15.53M 15.34M 15.56M 15.26M 14.98M 14.31M 13.67M 30.55M 30.22M 29.82M 28.62M
Research & Development
85.89M 82.84M 80.05M 77.71M 76.14M 78.99M 83.22M 84.67M 81.41M 76.77M 71.25M 68.9M 67.84M 67.04M 61.12M 53.91M 49.47M 43.72M
Other Expenses
-35K -35K -35K -23K -23K 31K 31K 209K 209K 155K 155K n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
105.23M 100.93M 97.96M 95.72M 93.57M 95.8M 99.2M 100.2M 96.75M 92.33M 86.52M 83.88M 82.15M 80.71M 91.67M 84.13M 79.29M 72.34M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a -31K -57K -57K -57K -26K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
105.27M 101M 98.05M 95.8M 93.65M 95.85M 99.22M 100.2M 96.75M 92.33M 86.52M 83.88M 82.15M 80.71M 91.67M 84.13M 79.29M 72.34M
Income Tax Expense
n/a n/a -17.28K -17.28K -17.28K -17.28K -2.01M 30.11M 31.21M 31.09M 32.47M 300K -818K -705K -106K -37K -90K -81K
Shares Outstanding (Basic)
132.18M 101.34M 90.15M 101.27M 101.27M 97.3M 44.63M 44.57M 44.43M 43.66M 31.82M 30.56M 30.25M 28.13M 25.32M 25.32M 21.75M 21.17M
Shares Outstanding (Diluted)
132.18M 101.34M 90.15M 101.27M 101.27M 97.3M 44.63M 44.57M 44.43M 43.66M 31.82M 30.56M 30.25M 28.13M 25.32M 25.32M 21.75M 21.17M
EPS (Basic)
-0.97 -0.98 -1.03 -1.23 -1.5 -1.83 -2.06 -4.36 -4.58 -4.76 -4.95 -3.01 -3.04 -3.14 -4.05 -3.75 -3.69 -3.77
EPS (Diluted)
-0.97 -0.98 -1.03 -1.23 -1.5 -1.83 -2.06 -4.36 -4.58 -4.76 -4.95 -3.01 -3.04 -3.14 -4.05 -3.74 -3.68 -3.76
EBITDA
-104.88M -100.89M -97.92M -95.68M -93.53M -95.75M -99.11M -100.09M -96.66M -92.25M -86.44M -83.78M -82.06M -80.62M -93.73M -86.3M -81.43M -74.49M
EBIT
-103.65M -99.64M -98.05M -95.8M -93.65M -95.85M -99.22M -100.2M -96.75M -92.33M -86.52M -83.88M -82.15M -80.71M -93.81M -86.28M -81.44M -74.49M
Depreciation & Amortization
163K 151K 134K 122K 114K 105K 111K 107K 90K 88K 77K 98K 97K 92K 85K 21K 48K 39K